Rafferty Asset Management, LLC Anavex Life Sciences Corp. Transaction History

Rafferty Asset Management, LLC

$29.4 Billion
Q2 2025

A detailed history of Rafferty Asset Management, LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 92,144 shares of AVXL stock, worth $830,217. This represents 0.0% of its overall portfolio holdings.

Number of Shares

92,144

Previous 127,454 27.7%

Holding current value

$830,217

Previous $1.09 Million 22.32%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$7.37 - $9.63 $260,234 - $340,035	-35,310 Reduced 27.7%	92,144 $849,000
Q1 2025 May 14, 2025	BUY	$7.85 - $13.46 $414,896 - $711,401	52,853 Added 70.85%	127,454 $1.09 Million
Q4 2024 Feb 14, 2025	SELL	$5.11 - $12.56 $332,073 - $816,211	-64,985 Reduced 46.56%	74,601 $801,000
Q3 2024 Nov 13, 2024	SELL	$4.11 - $7.04 $348,232 - $596,485	-84,728 Reduced 37.77%	139,586 $792,000
Q2 2024 Aug 13, 2024	SELL	$3.39 - $5.02 $1.51 Million - $2.24 Million	-445,631 Reduced 66.52%	224,314 $946,000
Q1 2024 May 13, 2024	BUY	$4.55 - $6.75 $1.99 Million - $2.96 Million	437,914 Added 188.73%	669,945 $3.41 Million
Q4 2023 Feb 13, 2024	SELL	$5.04 - $9.95 $195,335 - $385,632	-38,757 Reduced 14.31%	232,031 $2.16 Million
Q3 2023 Nov 13, 2023	SELL	$6.55 - $9.37 $523,174 - $748,419	-79,874 Reduced 22.78%	270,788 $1.77 Million
Q2 2023 Aug 11, 2023	SELL	$7.66 - $9.5 $877,782 - $1.09 Million	-114,593 Reduced 24.63%	350,662 $2.85 Million
Q1 2023 May 11, 2023	BUY	$8.32 - $11.75 $4,168 - $5,886	501 Added 0.11%	465,255 $3.99 Million
Q4 2022 Feb 13, 2023	BUY	$7.65 - $14.43 $1.45 Million - $2.74 Million	189,808 Added 69.03%	464,754 $4.3 Million
Q3 2022 Nov 14, 2022	BUY	$8.9 - $12.86 $953,457 - $1.38 Million	107,130 Added 63.84%	274,946 $2.84 Million
Q2 2022 Aug 12, 2022	SELL	$7.31 - $12.84 $1.46 Million - $2.57 Million	-200,283 Reduced 54.41%	167,816 $1.68 Million
Q1 2022 May 13, 2022	BUY	$9.74 - $17.69 $1.22 Million - $2.21 Million	125,185 Added 51.53%	368,099 $4.53 Million
Q4 2021 Feb 10, 2022	BUY	$16.88 - $23.31 $1.29 Million - $1.78 Million	76,282 Added 45.78%	242,914 $4.21 Million
Q3 2021 Nov 10, 2021	SELL	$16.82 - $25.75 $27,870 - $42,667	-1,657 Reduced 0.98%	166,632 $2.99 Million
Q2 2021 Aug 10, 2021	BUY	$10.16 - $28.86 $501,009 - $1.42 Million	49,312 Added 41.45%	168,289 $3.85 Million
Q1 2021 May 10, 2021	BUY	$5.17 - $16.13 $615,111 - $1.92 Million	118,977 New	118,977 $1.78 Million

Others Institutions Holding AVXL

# of Institutions

196

Shares Held

32M

Call Options Held

1.16M

Put Options Held

804K

View Full List

About ANAVEX LIFE SCIENCES CORP.

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $702M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

More about AVXL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Anavex Life Sciences Corp. Transaction History